Lecigon® based on European Medicines Agency (EMA) SmPC clinical trials

Long-Term Observational Study on Effectiveness and Safety of Lecigon in Patients With Advanced Parkinson's Disease

This study looks at how a medicine called Lecigon® works and its safety for people with advanced Parkinson's disease in their everyday lives. It gathers information from around 300 patients who are already using Lecigon® to help manage their symptoms that aren't well controlled by other treatments.